Clin2
NCT06854211Possibly a fitNot yet recruiting

Effects of morphine on breathing during sleep

OpioidsObstructive Sleep Apnea (OSA)

Part of Brain & nervous system, Lungs & breathing clinical trials.

This study tests how a single dose of morphine affects breathing during sleep in people both with and without sleep apnea. It aims to understand if opioids are riskier for people with sleep apnea.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
26 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be either a healthy person without sleep apnea or have mild to moderate sleep apnea (confirmed by a sleep test in the last 3 months).
  • You must not be taking any opioid pain medications at home or other drugs that affect breathing.
  • You must not have chronic lung diseases like COPD or asthma, or other serious breathing disorders.
  • You must not be taking certain antidepressants or other medications that interact with morphine.
  • If you are a woman, you must not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04538755Enrolling by invitation· Phase 1/Phase 2
Testing a new drug for moderate to severe sleep apnea

This trial tests a drug called DAW2020 to see if it can improve how your body controls breathing during sleep. You may qualify if you have moderate to severe sleep apnea and are otherwise healthy.

Boston, Massachusetts
NCT07332442Recruiting· Phase 3
CPAP and arousal in new sleep apnea patients

This study tests whether a common sleep apnea treatment (CPAP) affects how easily you wake up and the reasons behind it. It is for people who have just been diagnosed with sleep apnea and are not taking certain sleep medications or alcohol.

North Haven, Connecticut
NCT03858751Recruiting· Phase 1/Phase 2
Drug to activate a sleep-control pathway for sleep apnea

This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.

Boston, Massachusetts
NCT06091085Recruiting· Phase 1/Phase 2
Acetazolamide for sleep apnea in untreated patients

This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.

Boston, Massachusetts
NCT06286189Recruiting· Phase 1/Phase 2
Testing trazodone for sleep apnea

This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.

Boston, Massachusetts
NCT05293600Recruiting· Phase 1/Phase 2
Rescue medicine trial for sleep apnea after other treatments fail

This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.

Boston, Massachusetts

Hear when a new Opioids trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.